Trial Profile
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTIPLE-DOSE, TWO-CENTRE, SAFETY AND EFFICACY STUDY OF CO-ADMINISTRATION OF TESOFENSINE/METOPROLOL TREATMENT IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2020
Price :
$35
*
At a glance
- Drugs Metoprolol/tesofensine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- Sponsors Saniona
- 15 Sep 2017 Status changed to completed as reported by results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 12 Sep 2017 According to a Saniona media release, data from this study will be presented at European Association for the Study of Diabetes, EASD congress 2017.